Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The trabecular meshwork outflow pathway is an anatomically complex structure essential for maintaining normal intraocular pressure through regulated aqueous humor drainage. Its dysfunction—primarily at the level of the juxtacanalicular tissue (JCT)—underlies many forms of glaucoma due to increased hydraulic resistance.
Enhancing trabecular outflow facility by targeting cytoskeletal elements or ECM turnover within the trabecular meshwork.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trabecular Meshwork Outflow Pathway (TM).